Key facts
| Price (PPV) | 365 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | dabigatran étexilate |
| Class | Antithrombotic agents |
| ATC code | B01AE07 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 243 MAD |
| Data collected on | 9/8/2026 |
Indications
Prévention primaire des événements thromboemboliques veineux (ETEV) chez les patients adultes ayant bénéficié d’une chirurgie programmée pour prothèse totale de hanche ou de genou. Prévention de l’accident vasculaire cérébral (AVC) et de l’embolie systémique (ES) chez les patients adultes atteints de fibrillation atriale non valvulaire (FANV) et présentant un ou plusieurs facteurs de risque tels que : antécédent d’AVC ou d’accident ischémique transitoire (AIT) ; âge ≥ 75 ans ; insuffisance cardiaque (classe NYHA ≥ II) ; diabète ; hypertension artérielle. Traitement des thromboses veineuses profondes (TVP) et des embolies pulmonaires (EP), et prévention des récidives de TVP et d’EP chez l’adulte. Traitement des ETEV et prévention des récidives d’ETEV chez les patients pédiatriques âgés de moins de 18 ans. Pour connaître les formes pharmaceutiques appropriées en fonction de l’âge.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Pradaxa 110 mg (BOTTU S.A.) contains the same active substance as Pradaxa 110 mg (Dabigatran étexilate) at the same strength, but in a different pack: Boite de 60 at 733 MAD, i.e. 12.22 MAD per unit against 12.17 MAD for Pradaxa 110 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Pradaxa 110 mg | BOTTU S.A. | Boite de 60 | 733 MAD | 12.22 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Pradaxa 110 mg
Pradaxa 110 mg belongs to the antithrombotic agents therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Pradaxa 110 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Pradaxa 110 mg
Answers to common questions from Moroccan patients about this drug.